High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low… Grant US-11867688-B2 United States of America 09 Jan 2024
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1… Grant US-11497756-B2 United States of America 15 Nov 2022
Alvocidib prodrugs and their use as protein kinase inhibitors Grant US-11279694-B2 United States of America 22 Mar 2022
Methods of determining cellular chemosensitivity Grant US-11215608-B2 United States of America 04 Jan 2022
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer Grant US-11034710-B2 United States of America 15 Jun 2021
Combination therapies for treatment of cancer Grant US-10835537-B2 United States of America 17 Nov 2020
LIVE CELL IMAGING DYNAMIC BH3 PROFILING Application WO-2020176689-A1 World Intellectual Property Organisation (WIPO) 03 Sep 2020
High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low… Grant US-10761086-B2 United States of America 01 Sep 2020
Combination therapies for treatment of cancer Grant US-10682356-B2 United States of America 16 Jun 2020
Predicting response to alvocidib by mitochondrial profiling Grant US-10624880-B2 United States of America 21 Apr 2020
Combination therapies for treatment of cancer Grant US-10568887-B2 United States of America 25 Feb 2020
Alvocidib prodrugs having increased bioavailability Grant US-10562925-B2 United States of America 18 Feb 2020
Profiling peptides and methods for sensitivity profiling Grant US-10422788-B2 United States of America 24 Sep 2019
Predicting response to alvocidib by mitochondrial profiling Grant US-10357488-B2 United States of America 23 Jul 2019
Profiling peptides and methods for sensitivity profiling Grant US-10267787-B2 United States of America 23 Apr 2019
Alvocidib prodrugs having increased bioavailability Grant US-10259835-B2 United States of America 16 Apr 2019
Profiling peptides and methods for sensitivity profiling Grant US-10132797-B2 United States of America 20 Nov 2018